These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Peri-operative anticoagulant therapy--the case for an uninterrupted dose-adjusted warfarin regimen in the high-risk patient. Franz RC S Afr J Surg; 2006 Aug; 44(3):84, 86. PubMed ID: 16958233 [No Abstract] [Full Text] [Related]
6. Anticoagulant therapy for deep vein thrombosis: its proper application. Rohrer MJ; Anderson FA Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021 [No Abstract] [Full Text] [Related]
7. Study suggests limiting use of aspirin plus warfarin. Harv Heart Lett; 2007 May; 17(9):6. PubMed ID: 17526074 [No Abstract] [Full Text] [Related]
9. [Anticoagulant properties of the electrophoresis of pyrazolone preparations in ischemic heart disease]. Dizhenina II Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):47-50. PubMed ID: 6623978 [No Abstract] [Full Text] [Related]
10. [Acute coronary syndrome in patients using acetylsalicylic acid or warfarin]. Vik-Mo H; Hegbom K Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1105-6. PubMed ID: 15114389 [No Abstract] [Full Text] [Related]
11. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy. Laufman H Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618 [No Abstract] [Full Text] [Related]
12. [Treatment of pulmonary embolism. I. Treatment with heparin and oral anticoagulants]. Niewiarowski T; Filipecki S Pneumonol Pol; 1984 Sep; 52(9):447-52. PubMed ID: 6085154 [No Abstract] [Full Text] [Related]
13. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin? Jaff MR Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061 [TBL] [Abstract][Full Text] [Related]
14. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function. Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788 [No Abstract] [Full Text] [Related]
15. [Anti thrombotic therapy after coronary thrombolysis]. Tani S; Kanmatsuse K Nihon Rinsho; 2003 Apr; 61 Suppl 4():484-8. PubMed ID: 12735020 [No Abstract] [Full Text] [Related]
16. [Peculiarities of antithrombotic treatment in exacerbation of coronary heart disease and transcutaneous coronary interventions in patients suffering from atrial fibrillation and taking vitamin K antagonists (literature review)]. Iavelov IS Angiol Sosud Khir; 2010; 16(2):13-22. PubMed ID: 21032868 [TBL] [Abstract][Full Text] [Related]
17. An evaluation and improvement program for inpatient anticoagulant control. Phillips WS; Smith J; Greaves M; Preston FE; Channer KS Thromb Haemost; 1997 Feb; 77(2):283-8. PubMed ID: 9157582 [TBL] [Abstract][Full Text] [Related]
18. Treatment of pulmonary embolism in total hip replacement. Johnson R; Charnley J Clin Orthop Relat Res; 1977 May; (124):149-54. PubMed ID: 598069 [TBL] [Abstract][Full Text] [Related]
19. Operating on patients with warfarin: simpler alternative approach. Chiu D; Grigg M; Levi E ANZ J Surg; 2009 May; 79(5):409-10. PubMed ID: 19566535 [No Abstract] [Full Text] [Related]
20. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]